Literature DB >> 25246696

High Schistosoma mansoni disease burden in a rural district of western Zambia.

Mable M Mutengo1, James C L Mwansa1, Takafira Mduluza1, Sandie Sianongo1, James Chipeta2.   

Abstract

Schistosoma mansoni disease is endemic in most parts of rural Zambia, and associated complications are common. We conducted a cross-sectional study among 754 people in rural communities of Kaoma District, western Zambia to determine the burden of S. mansoni infection and associated morbidity. Parasitology and ultrasonography assessments were conducted on consenting participants. The overall prevalence of S. mansoni infection and geometric mean egg count (GMEC) were 42.4% (304) and 86.6 eggs per gram (95% confidence interval = 75.6-99.6), respectively. Prevalence was highest in the age group of 15-19 years old (adjusted prevalence ratio = 1.70, P = 0.017). S. mansoni-related portal fibrosis was detected in 26% of the participants screened. Participants above 39 years old were 2.93 times more likely to have fibrosis than the 7-9 years old age group (P = 0.004). The study highlights the high burden of S. mansoni disease in this area and calls for immediate interventions to avert complications associated with the disease. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2014        PMID: 25246696      PMCID: PMC4228894          DOI: 10.4269/ajtmh.13-0612

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  42 in total

1.  The influence of sampling effort and the performance of the Kato-Katz technique in diagnosing Schistosoma mansoni and hookworm co-infections in rural Côte d'Ivoire.

Authors:  M Booth; P Vounatsou; E K N'goran; M Tanner; J Utzinger
Journal:  Parasitology       Date:  2003-12       Impact factor: 3.234

2.  Large scale evaluation of WHO's ultrasonographic staging system of schistosomal periportal fibrosis in Ethiopia.

Authors:  Nega Berhe; Jonn T Geitung; Girmay Medhin; Svein G Gundersen
Journal:  Trop Med Int Health       Date:  2006-08       Impact factor: 2.622

3.  The effect of the number of stool samples on the observed prevalence and the infection intensity with Schistosoma mansoni among a population in an area of low transmission.

Authors:  Martin Johannes Enk; Anna Carolina Lustosa Lima; Sandra Costa Drummond; Virginia Torres Schall; Paulo Marcos Zech Coelho
Journal:  Acta Trop       Date:  2008-10-05       Impact factor: 3.112

4.  Increased detection of schistosomiasis with Kato-Katz and SWAP-IgG-ELISA in a Northeastern Brazil low-intensity transmission area.

Authors:  Teiliane Rodrigues Carneiro; Marta Cristhiany Cunha Pinheiro; Sara Menezes de Oliveira; Ana Lúcia de Paula Hanemann; José Ajax Nogueira Queiroz; Fernando Schemelzer Moraes Bezerra
Journal:  Rev Soc Bras Med Trop       Date:  2012 Jul-Aug       Impact factor: 1.581

5.  Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis.

Authors:  Birgitte J Vennervald; LeeCarol Kenty; Anthony E Butterworth; Curtis H Kariuki; Hilda Kadzo; Edmund Ireri; Clifford Amaganga; Gachuhi Kimani; Joseph Mwatha; Amos Otedo; Mark Booth; John H Ouma; David W Dunne
Journal:  Trop Med Int Health       Date:  2004-04       Impact factor: 2.622

6.  Schistosoma mansoni morbidity among adults in two villages along Lake Victoria shores in Mwanza District, Tanzania.

Authors:  Wabyahe L M Malenganisho; Pascal Magnussen; Henrik Friis; Julius Siza; Godfrey Kaatano; Mansuet Temu; Birgitte J Vennervald
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-04-28       Impact factor: 2.184

7.  Genetic control of severe egg-induced immunopathology and IL-17 production in murine schistosomiasis.

Authors:  Patrick M Smith; Mara G Shainheit; Lindsey E Bazzone; Laura I Rutitzky; Alexander Poltorak; Miguel J Stadecker
Journal:  J Immunol       Date:  2009-08-12       Impact factor: 5.422

Review 8.  The unacknowledged impact of chronic schistosomiasis.

Authors:  Charles H King; Madeline Dangerfield-Cha
Journal:  Chronic Illn       Date:  2008-03

9.  Day-to-day egg count fluctuation in Schistosoma mansoni infection and its operational implications.

Authors:  D Engels; E Sinzinkayo; B Gryseels
Journal:  Am J Trop Med Hyg       Date:  1996-04       Impact factor: 2.345

Review 10.  Chronic hepatosplenomegaly in African school children: a common but neglected morbidity associated with schistosomiasis and malaria.

Authors:  Shona Wilson; Birgitte J Vennervald; David W Dunne
Journal:  PLoS Negl Trop Dis       Date:  2011-08-30
View more
  12 in total

Review 1.  A meta-analysis of changes in schistosomiasis prevalence in Zambia: implications on the 2020 elimination target.

Authors:  Chester Kalinda; Mable Mutengo; Moses Chimbari
Journal:  Parasitol Res       Date:  2019-11-26       Impact factor: 2.289

2.  Direct Biomarkers of Microbial Translocation Correlate with Immune Activation in Adult Zambians with Environmental Enteropathy and Hepatosplenic Schistosomiasis.

Authors:  Patrick Kaonga; Evans Kaimoyo; Ellen Besa; Kanekwa Zyambo; Edford Sinkala; Paul Kelly
Journal:  Am J Trop Med Hyg       Date:  2017-11       Impact factor: 2.345

3.  Rifaximin Reduces Markers of Inflammation and Bacterial 16S rRNA in Zambian Adults with Hepatosplenic Schistosomiasis: A Randomized Control Trial.

Authors:  Edford Sinkala; Kanekwa Zyambo; Ellen Besa; Patrick Kaonga; Bright Nsokolo; Violet Kayamba; Michael Vinikoor; Rabison Zulu; Martin Bwalya; Graham R Foster; Paul Kelly
Journal:  Am J Trop Med Hyg       Date:  2018-02-08       Impact factor: 2.345

Review 4.  Schistosomiasis in Zambia: a systematic review of past and present experiences.

Authors:  Chester Kalinda; Moses J Chimbari; Samson Mukaratirwa
Journal:  Infect Dis Poverty       Date:  2018-04-30       Impact factor: 4.520

5.  Contribution of Schistosoma mansoni to systemic inflammation and microbial translocation among people with HIV in Zambia.

Authors:  Briana D Furch; Simutanyi Mwakamui; Sandie Sianongo; Kanekwa Zyambo; Douglas C Heimburger; John R Koethe; Paul Kelly
Journal:  Trans R Soc Trop Med Hyg       Date:  2022-02-01       Impact factor: 2.455

6.  Low IL-6, IL-10, and TNF-α and High IL-13 Cytokine Levels Are Associated with Severe Hepatic Fibrosis in Schistosoma mansoni Chronically Exposed Individuals.

Authors:  Mable M Mutengo; Takafira Mduluza; Paul Kelly; James C L Mwansa; Geoffrey Kwenda; Patrick Musonda; James Chipeta
Journal:  J Parasitol Res       Date:  2018-01-23

7.  Prevalence and intensity of Schistosoma haematobium infection among schoolchildren in central Zambia before and after mass treatment with a single dose of praziquantel.

Authors:  Mohamed A Shehata; Mubanga F Chama; Evelyn Funjika
Journal:  Trop Parasitol       Date:  2018-05-28

8.  Hepatosplenic schistosomiasis in Zambian adults is characterized by increased liver stiffness: A nested case-control study.

Authors:  Edford Sinkala; Michael Vinikoor; Alice Miyanda Siyunda; Kanekwa Zyambo; Ellen Besa; Bright Nsokolo; Gilles Wandeler; Graham R Foster; Paul Kelly
Journal:  Heliyon       Date:  2020-07-28

9.  Propranolol Reduces Portal Vein Diameter in Schistosomal Liver Disease with Portal Hypertension: A Prospective Cohort Study.

Authors:  Edford Sinkala; Michael Vinikoor; Kanekwa Zyambo; Ellen Besa; Bright Nsokolo; Paul Kelly
Journal:  Am J Trop Med Hyg       Date:  2020-04       Impact factor: 2.345

10.  PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?

Authors:  Raphael Taiwo Aruleba; Tayo Alex Adekiya; Babatunji Emmanuel Oyinloye; Priscilla Masamba; Londiwe Simphiwe Mbatha; Ashley Pretorius; Abidemi Paul Kappo
Journal:  Infect Disord Drug Targets       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.